Biotech · Private company
Cantargia AB
Track this companyFree. Adds Cantargia AB to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- CAN04Phase 1 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- CarboplatinPhase 1 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- PemetrexedPhase 1 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Immunoprevention for High-risk Lung LesionsPHASE2 · RECRUITING · started May 21, 2026ClinicalTrials.gov NCT07284485 · fetched Nov 12, 2026
- Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRCPHASE1_PHASE2 · RECRUITING · started Dec 1, 2025ClinicalTrials.gov NCT07281716 · fetched Nov 12, 2026
- A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid TumorsPHASE1 · COMPLETED · started Sep 24, 2020ClinicalTrials.gov NCT04452214 · fetched Nov 12, 2026